Inhibrx Biosciences, Inc. (INBX) vs Keros Therapeutics, Inc. (KROS)
Detailed comparison between Inhibrx Biosciences, Inc., Keros Therapeutics, Inc..Total Return (%)
Inhibrx Biosciences, Inc. (INBX)Keros Therapeutics, Inc. (KROS)
Which stock do you think will perform better?
Inhibrx Biosciences, Inc.
INBX
Keros Therapeutics, Inc.
KROS
| Metric | Inhibrx Biosciences, Inc. (INBX) | Keros Therapeutics, Inc. (KROS) |
|---|---|---|
| Current Price | $81.30 | $17.22 |
| Change | 1.46 (1.83%) | 0.40 (2.38%) |
| Market Cap | $1.18B | $0.52B |
| Trailing P/E | 0.00 | 11.04 |
| Forward P/E | -7.37 | -3.02 |
| Dividend Yield | 0.00% | 0.00% |
| 52-Week High | $86.64 | $72.37 |
| 52-Week Low | $10.80 | $9.12 |
| Beta | 0.00 | 0.00 |
| Earnings Per Share | $-11.96 | $1.56 |
Processing data. Please try again later.
Average Return
| Symbol | 1 Month | Year-to-date | 1 Year | 5 Years | 10 Years | Max |
|---|---|---|---|---|---|---|
| INBX | 157.93% | 497.79% | 477.41% | 550.05% | 550.05% | 550.05% |
| KROS | 10.67% | 51.19% | -69.21% | -77.40% | -14.24% | -14.24% |